Related Experiment Videos
Percutaneous ethanol injection therapy for liver tumors
1Department of Gastroenterology, University of Tokyo, Hongo 7-3-1, Bunkyo-ku, 113 8655, Tokyo, Japan. siina-2im@h.u-tokyo.ac.jp
Summary
Percutaneous ethanol injection therapy (PEIT) effectively treats liver tumors, particularly hepatocellular carcinoma (HCC), offering high long-term survival rates and serving as a viable alternative to surgery for small HCC cases.
Area of Science:
- Hepatology and Interventional Radiology
Background:
- Percutaneous ethanol injection therapy (PEIT) is a common treatment for liver tumors.
- Hepatocellular carcinoma (HCC) is a primary indication for PEIT.
Purpose of the Study:
- To provide a comprehensive overview of PEIT for liver tumors.
- To discuss patient selection, technique, efficacy evaluation, outcomes, and complications of PEIT.
Main Methods:
- Review of existing literature and clinical practices regarding PEIT.
- Analysis of histopathologic findings, imaging, and serum tumor markers to assess efficacy.
Main Results:
- PEIT demonstrates significant anticancer effects.
- High long-term survival rates are achievable with PEIT.
- PEIT is a recognized alternative to surgery for small HCC.
Conclusions:
- PEIT is an established and effective treatment modality for liver tumors, especially HCC.
- The therapy offers favorable long-term outcomes and safety profiles.
- Further understanding of PEIT's application and integration with other therapies is beneficial.